Stay updated on Uproleselan with Chemotherapy for AML Clinical Trial
Sign up to get notified when there's something new on the Uproleselan with Chemotherapy for AML Clinical Trial page.

Latest updates to the Uproleselan with Chemotherapy for AML Clinical Trial page
- Check7 days agoChange DetectedPage revision updated from v3.6.5 to v3.6.6; this represents a minor update to the page's metadata or display without changing study details.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRevision metadata on the page was updated from v3.6.4 to v3.6.5, reflecting a version upgrade. The change does not affect the study data or displayed information.SummaryDifference0.0%

- Check43 days agoChange DetectedThe revision tag on the page updated from v3.6.3 to v3.6.4. This indicates a new published version of the page, likely reflecting administrative updates rather than user-facing content changes.SummaryDifference0.0%

- Check64 days agoChange DetectedThe page now shows a new revision tag, v3.6.3, replacing the previous v3.6.2. This appears to be a small maintenance update and does not alter the study information, eligibility criteria, or locations.SummaryDifference0.0%

- Check71 days agoChange Detected- The page revision tag was updated from v3.6.0 to v3.6.2, reflecting a minor metadata update to the study page.SummaryDifference0.0%

- Check86 days agoChange DetectedThe study record now states that recruitment has ended with 'No longer looking for participants.' This indicates the trial is terminated and no new participants are being enrolled.SummaryDifference0.3%

Stay in the know with updates to Uproleselan with Chemotherapy for AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Uproleselan with Chemotherapy for AML Clinical Trial page.